Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

BACKGROUND & AIMS: Therapeutic drug monitoring (TDM) is widely available for biologic therapies in patients with inflammatory bowel disease (IBD). We reviewed current data and provided expert opinion regarding the clinical utility of TDM for biologic therapies in IBD. METHODS: We used a modified...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Gastroenterol Hepatol
Auteurs principaux: Papamichael, Konstantinos, Cheifetz, Adam S., Melmed, Gil Y., Irving, Peter M., Casteele, Niels Vande, Kozuch, Patricia L., Raffals, Laura E., Baidoo, Leonard, Bressler, Brian, Devlin, Shane M., Jones, Jennifer, Kaplan, Gilaad G., Sparrow, Miles P., Velayos, Fernando S., Ullman, Thomas, Siegel, Corey A.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6661210/
https://ncbi.nlm.nih.gov/pubmed/30928454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2019.03.037
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires